Daphne Zohar's most recent trade in Seaport Therapeutics Inc. was a trade of 1,486,786 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seaport Therapeutics Inc | Daphne Zohar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 1,486,786 | 1,486,786 | - | - | Stock Option (Right to Buy) | |
| Seaport Therapeutics Inc | Daphne Zohar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 271,813 | 271,813 | - | - | Stock Option (Right to Buy) |